Get the Stockscreener App
0.235
0.30%
-0.0007
After Hours:
.23
-0.005
-2.13%
Icecure Medical Ltd stock is traded at $0.235, with a volume of 522.39K.
It is down -0.30% in the last 24 hours and down -34.25% over the past month.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
See More
Previous Close:
$0.2357
Open:
$0.235
24h Volume:
522.39K
Relative Volume:
0.89
Market Cap:
$19.09M
Revenue:
$3.38M
Net Income/Loss:
$-15.06M
P/E Ratio:
-1.0021
EPS:
-0.2345
Net Cash Flow:
$-15.50M
1W Performance:
+2.26%
1M Performance:
-34.25%
6M Performance:
-64.39%
1Y Performance:
-76.96%
1-Day Range:
$0.2293
$0.2425
1-Week Range:
$0.215
$0.2425
52-Week Range:
$0.215
$1.40
Icecure Medical Ltd Stock (ICCM) Company Profile
Compare ICCM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
0.235 | 19.15M | 3.38M | -15.06M | -15.50M | -0.2345 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Icecure Medical Ltd Stock (ICCM) Latest News
Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ... By GuruFocus - Investing.com Canada
Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Rob - GuruFocus
Icecure Medical Earnings Call Highlights Growth Momentum - TipRanks
IceCure Medical presents positive ProSense cryoablation data - grafa.com
IceCure's ProSense® Reports Nearly 90% Recurrence-Free Rate for - GuruFocus
IceCure Showcases Strong ProSense® Cryoablation Data and Surge in Clinical Interest at ECIO 2026 - TipRanks
IceCure Medical (ICCM) highlights kidney and breast cryoablation data at ECIO 2026 - Stock Titan
IceCure Medical Ltd. Reports Nearly 90% Recurrence-Free Rate For Cryoablation Of Kidney Cancer And Showcases ProSense At ECIO 2026 - marketscreener.com
[Form 4] IceCure Medical Ltd. Insider Trading Activity - Stock Titan
IceCure Medical : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
IceCure Medical (ICCM) CFO reports 400,000 RSUs equity grant - Stock Titan
IceCure Medical Ltd. (ICCM) reports Q1 loss, lags revenue estimates - MSN
IceCure Medical Ltd.Ordinary Shares (NQ: ICCM - The Chronicle-Journal
Maxim Group Maintains Icecure Medical(ICCM.US) With Buy Rating, Maintains Target Price $1 - Moomoo
Maxim Group Maintains Icecure Medical(ICCM.US) With Buy Rating, Cuts Target Price to $1 - Moomoo
ICCM Maintained by Maxim Group -- Price Target Lowered to $1.00 - GuruFocus
IceCure Medical Wins Nasdaq Extension to Restore Minimum Bid Compliance - The Globe and Mail
IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement - The Malaysian Reserve
Icecure granted 180-day extension by Nasdaq to regain compliance with minimum bid requirement - marketscreener.com
IceCure Medical (ICCM) wins new 180-day window to meet Nasdaq $1 bid - Stock Titan
IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Requirement - Moomoo
IceCure Medical Ltd (NASDAQ:ICCM) Q1 2026 Earnings Call Transcript - Insider Monkey
IceCure given until Nov. 9 to lift Nasdaq share price above $1 - Stock Titan
IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America - StreetInsider
ICECURE MEDICAL ($ICCM) Releases Q1 2026 Earnings - Moomoo
[424B5] IceCure Medical Ltd. Prospectus Supplement (Debt Securities) - Stock Titan
IceCure Medical Sets Up At-the-Market Equity Program With A.G.P./Alliance Global Partners - TipRanks
[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer) | ICCM SEC FilingForm 6-K - Stock Titan
ICCM: Strong Q1 Revenue Growth Signals Positive Market Momentum - GuruFocus
IceCure (ICCM) Q1 2026 Earnings Transcript - AOL.com
IceCure Reports First Quarter 2026 Financial Results: ProSense® - GuruFocus
ICCM: Q1 2026 revenue up 26% year-over-year, driven by U.S. growth and post-FDA commercial momentum - TradingView
ICCM: Q1 2026 saw 26% revenue growth and accelerating U.S. adoption following FDA clearance - TradingView
ICCM: ProSense® sales soared post-FDA clearance, fueling robust revenue growth and U.S. adoption - TradingView
IceCure Medical Posts Strong Q1 2026 ProSense® Growth in U.S. After FDA Clearance - TipRanks
IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
IceCure Medical (NASDAQ: ICCM) grows Q1 2026 revenue but posts $4.3M loss - Stock Titan
IceCure Medical (NASDAQ:ICCM) Shares Slide Over 7% Premarket After Q1 Revenue Miss - ChartMill
Press Release: IceCure Reports First Quarter 2026 Financial Results: ProSense(R) Sales Increase Substantially in the U.S. and North America - Moomoo
IceCure Medical Q1 2026 Earnings Call Transcript - MarketBeat
IceCure Medical Shareholders Approve Agenda Item at May 11 Special Meeting After Initial Adjournment - TipRanks
IceCure Medical (ICCM) shareholders approve agenda item after adjourned meeting - Stock Titan
Why Has IceCure Medical's Stock Price Collapsed - Kavout
ICCM Stock Price, Quote & Chart | ICECURE MEDICAL LTD (NASDAQ:ICCM) - ChartMill
IceCure Medical Faces Certified Class Action in Israel Over 2021 Private Placement - TipRanks
IceCure Medical to Release First Quarter 2026 Financial Results on May 12 - geneonline.com
IceCure to release Q1 results before market, webcast at 11 a.m. EDT - Stock Titan
IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026 - marketscreener.com
IceCure Showcases ProSense® Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market - Quantisnow
A. G. P. Initiates Icecure Medical(ICCM.US) With Buy Rating, Announces Target Price $1 - Moomoo
IceCure Medical Ltd. (ICCM) Q2 Earnings Surpass Estimates - MSN
Icecure Medical Ltd Stock (ICCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):